1. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents;Ali;N. Engl. J. Med.,2021
2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021
3. Evaluation of mRNA-1273 Covid-19 vaccine in children 6 to 11 Years of age;Creech;N. Engl. J. Med.,2022
4. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N. Engl. J. Med.,2020
5. Surie D, Bonnell L, Adams K, Gaglani M, Ginde AA, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A et al: Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022. MMWR Morb Mortal Wkly Rep 2022, 71(42):1327-1334.